Human Liver Tumor-Associated Endothelial Cells

Osimertinib Effectively Inhibits HCC Angiogenesis in Primary Human Liver Tumor-Associated Endothelial Cells In Vitro.

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally. Osimertinib, a selective EGFR tyrosine kinase inhibitor approved for non-small cell lung cancer, has shown anti-cancer activity in EGFR-independent pathways. Huang's team investigated the effects of osimertinib on HCC and angiogenesis, and explored its potential synergistic effects with venetoclax, a selective Bcl-2 inhibitor. Human liver tumor-associated endothelial cells (HLTEC) were used to model HCC angiogenesis. HLTEC and osimertinib were plated on a Matrigel matrix enriched with exogenous factors and extracellular matrix. In the control group, HLTEC formed extensive and smooth tubular structures, whereas osimertinib-treated HLTEC failed to align and form a capillary network (Fig. 1A). Quantification showed that osimertinib inhibited HLTEC capillary network formation in a dose-dependent manner (Fig. 1B). Additionally, osimertinib induced apoptosis in HLTEC (Fig. 1C). A time course analysis revealed that osimertinib did not induce HLTEC apoptosis within 6 hours, but apoptosis appeared to begin after 24 hours (Fig. 1D). Therefore, ruling out the possibility that the anti-angiogenic effect of osimertinib was derived from its ability to induce apoptosis.

Fig. 1. Osimertinib inhibits HCC angiogenesis in vitro of primary human liver tumor associated endothelial cell (Huang, Q., He, S., et al., 2023).

Genetic Difference of Sk-Hep1-Derived Tumor Tissue between Male and Female Mice

Estrogen is considered to be one of the factors influencing liver cancer, however, its role in liver cancer progression remains unclear. Oh, S. et al. investigated how estrogen influences the progression of liver cancer by transplanting SK-Hep1 (human liver tumor associated endothelial cells) into ovariectomized mice and examining the growth of tumor tissues after estrogen treatment (Fig. 2a). From the total RNA sequencing data, 15 genes, including KiSS-1 metastasis-suppressor, Golgi transport 1A, meiosis expressed gene 1 homolog, MMP7, oxidized low density lipoprotein, transmembrane protein 52B, GSG1, ABI family member 3, signal-regulatory protein gamma, hemopoietic cell kinase, RP11-219E24.1, BOC cell adhesion associated, lysosomal-associated membrane protein, C6orf15, and HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 were exclusively expressed in female-derived tumors (Fig. 2b). Among these genes, MMP7, GSG1, and C6orf15 significantly affected liver cancer patients' overall survival (Fig. 2c) and could serve as predictive biomarkers. Low MMP7 and high GSG1 and C6orf15 expression levels correlated with prolonged survival. Protein levels of these genes were higher in female tumors (Fig. 2d), indicating gene expression variability based on endogenous factors.

Fig. 2. Difference in gene expression between male and female mice bearing SK-Hep1-derived tumor (Oh S, Kwon HJ, et al., 2021).